MarketCap
Facebook
X
TelegramHeat Biologics, Inc. Financial Ratios 2020-2011 | HTBX
Brief overview of Heat Biologics, Inc.'s valuation and returns
The review covers five available annual periods spanning 2016 to 2020.
The latest available valuation ratios are P/S 11.11x (median 7.16x), P/B 0.28x (median 0.82x). On average, multiples differ from their five-year medians by only -5.1%. Valuation is near its familiar historical range.
The latest available business-quality ratios are ROE -22.6%, ROA -21%, ROCE -20.7%. Negative returns point to losses or poor capital efficiency. Valuation multiples are less informative in this setting.
Overall assessment
Heat Biologics, Inc.'s valuation and business quality look relatively balanced, with no pronounced distortion in either direction.
Annual Financial Ratios Heat Biologics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.3 | -0.4 | -1.6 | -0.9 | -1.4 | -1.0 | -3.1 | -3.3 | - | - |
P/S |
11.1 | 2.7 | 4.3 | 7.2 | 52.2 | - | - | - | - | - |
EV/EBITDA |
-0.9 | 0.0 | -0.2 | -0.1 | -0.8 | -1.0 | -3.0 | -3.7 | - | - |
PEG |
-0.04 | 0.01 | 0.02 | 0.02 | 0.02 | -0.03 | 0.13 | -0.04 | - | - |
P/B |
0.3 | 0.6 | 0.8 | 1.9 | 2.6 | 8.0 | 3.4 | 1.3 | - | - |
P/CF |
-1.5 | -0.6 | -1.1 | -1.7 | -1.3 | -1.1 | -3.6 | -4.4 | - | - |
ROE % |
-22.56 | -152.13 | -52.02 | -204.84 | -183.83 | -813.43 | -106.87 | -40.11 | - | - |
ROA % |
-20.97 | -77.12 | -41.66 | -58.65 | -141.33 | -153.54 | -74.07 | -37.84 | - | - |
ROCE % |
-20.73 | -110.70 | -53.10 | -133.14 | -179.79 | -335.98 | -91.32 | -30.06 | - | - |
DSO |
21.9 | 4.2 | 1.8 | 3.6 | 87.9 | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Heat Biologics, Inc., allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Russia
USA
Canada
Germany
China
Israel
France
Britain
Belgium
